Elevance Health, Inc. (ELV)
NYSE: ELV · Real-Time Price · USD
348.38
-1.50 (-0.43%)
At close: Dec 29, 2025, 4:00 PM EST
348.80
+0.42 (0.12%)
Pre-market: Dec 30, 2025, 5:45 AM EST
Elevance Health Employees
Elevance Health had 104,200 employees as of December 31, 2024. The number of employees decreased by 700 or -0.67% compared to the previous year.
Employees
104,200
Change (1Y)
-700
Growth (1Y)
-0.67%
Revenue / Employee
$1,869,674
Profits / Employee
$53,100
Market Cap
77.42B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 104,200 | -700 | -0.67% |
| Dec 31, 2023 | 104,900 | 2,600 | 2.54% |
| Dec 31, 2022 | 102,300 | 4,100 | 4.18% |
| Dec 31, 2021 | 98,200 | 14,800 | 17.75% |
| Dec 31, 2020 | 83,400 | 12,800 | 18.13% |
| Dec 31, 2019 | 70,600 | 6,700 | 10.49% |
| Dec 31, 2018 | 63,900 | 7,900 | 14.11% |
| Dec 31, 2017 | 56,000 | 3,000 | 5.66% |
| Dec 31, 2016 | 53,000 | 0 | - |
| Dec 31, 2015 | 53,000 | 1,500 | 2.91% |
| Dec 31, 2014 | 51,500 | 3,300 | 6.85% |
| Dec 31, 2013 | 48,200 | 4,700 | 10.80% |
| Dec 31, 2012 | 43,500 | 5,800 | 15.38% |
| Dec 31, 2011 | 37,700 | 200 | 0.53% |
| Dec 31, 2010 | 37,500 | -3,000 | -7.41% |
| Dec 31, 2009 | 40,500 | -2,400 | -5.59% |
| Dec 31, 2008 | 42,900 | 1,200 | 2.88% |
| Dec 31, 2007 | 41,700 | -300 | -0.71% |
| Dec 31, 2006 | 42,000 | 0 | - |
| Dec 31, 2005 | 42,000 | 4,000 | 10.53% |
| Dec 31, 2004 | 38,000 | 17,870 | 88.77% |
| Dec 31, 2003 | 20,130 | 630 | 3.23% |
| Dec 31, 2002 | 19,500 | 4,700 | 31.76% |
| Dec 31, 2001 | 14,800 | - | - |
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
ELV News
- 7 days ago - Elevance Health to Hold Conference Call and Webcast to Discuss Fourth Quarter and Full Year 2025 Results on January 28, 2026 - Business Wire
- 17 days ago - Elevance Health Reflects On The Changed Role of Health Plans - Business Wire
- 17 days ago - AM Best Takes Various Credit Rating Actions on Elevance Health, Inc. and Most of Its Subsidiaries - Business Wire
- 19 days ago - Elevance Health Board Welcomes Amy Schulman as New Director, Reflecting Ongoing Commitment to Governance Excellence - Business Wire
- 21 days ago - Anthem Blue Cross and Blue Shield Donates Over $60,000 to Support Holiday Food Distributions Across New York - Business Wire
- 21 days ago - Impax U.S. Sustainable Economy Fund Q3 2025 Contributors And Detractors - Seeking Alpha
- 24 days ago - Elevance Health Expands Virtual Assistant to Help Members Navigate Healthcare with Confidence - Business Wire
- 4 weeks ago - Elevance Health: The Potential Turnaround The Market Isn't Pricing In - Seeking Alpha